Liminal BioSciences is a global clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel treatments for patients suffering from diseases with a high unmet medical need. Our research program is focused on inflammatory, fibrotic and metabolic conditions in patients with liver, respiratory or renal disease, with an emphasis on rare or orphan diseases.
Our expertise in small molecules has enabled a strong late-stage pipeline with potential best-in-class drugs.
Why Invest? Our world-class research and development team are constantly pushing boundaries to make discoveries which help the scientific community better understand rare disease and orphan drug development, especially effecting the liver, kidney and respiratory system.